NSEGeneral Updates21h ago · 24 Sept 2026, 09:36 pm
General Updates
RPG Life Sciences Limited · RPGLIFE
✦ AI SummaryM&A
RPG Life Sciences Limited has completed the acquisition of Actis Generics Private Limited, making it a subsidiary of the company, effective September 24, 2026.
Analysis Scores
Earnings Impact3/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Update on share purchase agreement dated July 29, 2026, with Actis Generics Private Limited
Attachments (1)
📄pdf
Download →
RPGLIFE_24092026213619_Intimation_letter.pdf
View document text
September 24, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, 5th Floor, Corporate Relationship Department
Plot No. C-1, G- Block, 25, P.J. Towers,
Bandra - Kurla Complex, Bandra (East) Dalal Street,
Mumbai – 400 051. Mumbai 400 001.
Symbol: RPGLIFE Scrip Code: 532983
Dear Sir/Madam,
Subject: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’).
Further to our letter dated July 29, 2026, informing you about the execution of Share Purchase
Agreement (‘SPA’) by RPG Active Pharma Limited (RPGAP) for acquisition of entire stake of Actis
Generics Private Limited (‘Actis’).
We wish to inform you that in terms of the SPA, the said transaction has been completed, today i.e.
September 24, 2026.
Effective from September 24, 2026, Actis has became subsidiary of the Company and the wholly owned
subsidiary of RPGAP.
Kindly take the same on records.
Yours sincerely,
For RPG Life Sciences Limited
Rajesh Shirambekar
Head – Legal & Company Secretary